• Late Decentration of IOLs – An Enigma

This phenomenon occurs when an implanted IOL shifts from its original position after surgery, affecting vision quality. Dr. Vasavada, known for his expertise in cataract surgery, delved into potential causes, preventive strategies and treatment options for this condition.

• How to talk to patients about IOL options

With great opportunity in the world of IOLs also comes a challenge: how to discuss these options efficiently in a targeted manner without overwhelming or causing confusion for the patient.

• Latest lessons learned with the Light Adjustable Lens

The Light Adjustable Lens (RxSight) has been available for several years now, but doctors are still fine-tuning their experience and efficiencies with the lens. In this article, four ophthalmologists provided their insights on bringing the Light Adjustable Lens into practice after many years of experience.

• Allergies or intolerance to materials used in cataract surgery

While true allergies to materials used during cataract surgery are generally uncommon, this is a topic that physicians may need to discuss with patients. Two physicians highlighted some of the key concerns they hear from patients and how they approach these concerns to identify real allergies versus intolerance to certain products.

• Crosslinking: then, now, and next up

With new techniques in (or having recently completed) Phase 3 clinical trials to potentially move crosslinking to the next stage in the U.S., EyeWorld spoke with specialists to look back at where keratoconus monitoring and treatment was, where it is now, and what could be coming.

• A shift toward RLE

With expanding options in refractive surgery for different ages, many surgeons are seeing an uptick in refractive lens exchange (RLE). Three physicians discussed their approach to RLE.

• AI expanding in refractive surgery

What’s the latest tool in the refrac­tive surgeon’s toolbox? As with many fields from marketing to medicine, it’s artificial intelli­gence (AI). EyeWorld spoke with several surgeons to learn more about how AI is impacting refractive surgery, as well as some other areas of the anterior segment.

• Expanded treatment options in dry eye

Dry eye continues to be an important topic because of the many patients impacted and different ways it can present. Two cornea specialists highlighted some of the newer treatment options and how they are handling dry eye in their practice, including how they have updated their approach with experience.

• Corneal cell therapy: current status and looking to the future

Corneal cell therapy is under investigation by various companies as an alternative to corneal transplantation and therapy for several corneal diseases. Physicians involved in research in this area weighed in on the approaches and current status.

• Preservatives in ophthalmic medications and alternative strategies

Many patients use drops to help with a variety of ophthalmic issues, however, one thing to consider is the formulation of these products, specifically if they have preser­vatives. Three ophthalmologists discussed the precautions with preservatives and shared the importance of monitoring for toxicity and po­tentially finding alternative treatment option.

• Is gonioscopy dead?

While glaucoma specialists who spoke with EyeWorld said gonioscopy remains a vital and valuable tool in the clinic, newer imaging systems can help visualize the angle as well, overcoming some limitations of gonioscopy and becoming a complementary technology.

• Helping glaucoma patients understand their disease and treatment options

With a disease like glaucoma, where management of progression is often dependent on patient compliance with treatment plans, getting patients to truly understand their condition is vital. Glaucoma specialists shared how they help patients understand glaucoma.

• AI for Surgical Training – A look into the future